336.74
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$336.00
Offen:
$336.74
24-Stunden-Volumen:
3.31M
Relative Volume:
1.38
Marktkapitalisierung:
$181.29B
Einnahmen:
$35.89B
Nettoeinkommen (Verlust:
$7.01B
KGV:
26.03
EPS:
12.9352
Netto-Cashflow:
$11.54B
1W Leistung:
+5.17%
1M Leistung:
+14.60%
6M Leistung:
+28.39%
1J Leistung:
+13.79%
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
336.74 | 180.93B | 35.89B | 7.01B | 11.54B | 12.94 |
|
LLY
Lilly Eli Co
|
1,025.28 | 915.49B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
195.93 | 470.41B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
232.36 | 410.55B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
131.26 | 253.11B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
92.92 | 230.65B | 63.90B | 19.05B | 13.05B | 7.5596 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Oak Harvest Investment Services Acquires 983 Shares of Amgen Inc. $AMGN - MarketBeat
Impax Asset Management Group plc Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Purchases 3,550 Shares of Amgen Inc. $AMGN - MarketBeat
Is Amgen Inc. (AMG) stock good for wealth creationTrade Ideas & Daily Profit Maximizing Tips - newser.com
Advisors Capital Management LLC Purchases 4,326 Shares of Amgen Inc. $AMGN - MarketBeat
How supply shortages influence Amgen Inc. (AMG) stockWeekly Volume Report & Free Reliable Trade Execution Plans - newser.com
Amgen’s 29.9% Rally in 2025 Sparks Debate After New Drug Approvals - simplywall.st
Why Amgen Inc. (AMG) stock could rally strongly2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
How Amgen Inc. stock compares to growth peers2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - newser.com
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks - Benzinga
Why analysts maintain buy rating on Amgen Inc. (AMG0) stock2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Jim Cramer on Amgen: “Why Not Go Buy That?” - MSN
Scotiabank Begins Coverage on Amgen (NASDAQ:AMGN) - MarketBeat
WASHINGTON TRUST Co Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Rating Update: Piper Sandler Raises Price Target | AMGN Stock News - GuruFocus
Police & Firemen s Retirement System of New Jersey Has $22.79 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Penserra Capital Management LLC Decreases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Insider Sold Shares Worth $2,317,071, According to a Recent SEC Filing - MarketScreener
How dovish Fed policy supports Amgen Inc. (AMG) stockM&A Rumor & Low Volatility Stock Suggestions - newser.com
Is Amgen Inc. (AMG) stock a buy on weaknessJuly 2025 PreEarnings & Real-Time Price Movement Reports - newser.com
Amgen EVP Gordon Murdo sells $2.3m in stock - Investing.com India
[Form 4] AMGEN INC Insider Trading Activity - Stock Titan
Why Amgen Stock Edged Past the Market on Thursday - The Globe and Mail
Published on: 2025-11-13 16:29:30 - newser.com
Is Amgen Inc. stock ready for a breakoutEarnings Overview Report & Reliable Entry Point Alerts - newser.com
Trade Tracker: Bill Baruch buys more Amgen - MSN
2 Supercharged Dividend Stocks to Buy Now - Finviz
Jim Cramer Shows Confidence in Amgen - MSN
Delivering Excellence: Celebrating Quality, Safety & Compliance Month at Amgen - Amgen
A Closer Look at Amgen's Options Market Dynamics - Benzinga
Wealth Alliance LLC Has $3.58 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Geode Capital Management LLC Buys 291,271 Shares of Amgen Inc. $AMGN - MarketBeat
PNC Financial Services Group Inc. Sells 14,067 Shares of Amgen Inc. $AMGN - MarketBeat
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference - GlobeNewswire Inc.
M&G PLC Buys 19,708 Shares of Amgen Inc. $AMGN - MarketBeat
KBC Group NV Sells 7,212 Shares of Amgen Inc. $AMGN - MarketBeat
Institutional scanner results for Amgen Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
Ironwood Investment Counsel LLC Acquires 8,497 Shares of Amgen Inc. $AMGN - MarketBeat
National Pension Service Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
Scotiabank Initiates Amgen at Sector Outperform With $385 Price Target - MarketScreener
65,790 Shares in Amgen Inc. $AMGN Bought by ABN Amro Investment Solutions - MarketBeat
Where Does Amgen Stand After 15% Surge and New Pipeline Approvals in 2025? - Yahoo Finance
Key facts: Amgen Fuels Dow's Record Close; Shares Up 3.7%; AI's Impact Discussed - TradingView
Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer - Insider Monkey
Amgen (NASDAQ:AMGN) Given New $285.00 Price Target at Deutsche Bank Aktiengesellschaft - MarketBeat
Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week - Yahoo Finance
Vise Technologies Inc. Invests $4.30 Million in Amgen Inc. $AMGN - MarketBeat
Bailard Inc. Purchases 2,925 Shares of Amgen Inc. $AMGN - MarketBeat
denkapparat Operations GmbH Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Boston Partners Sells 56,489 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Holdings Lowered by Forsta AP Fonden - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Amgen Inc-Aktie (AMGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gordon Murdo | EVP, Global Commercial Ops |
Nov 12 '25 |
Sale |
336.83 |
6,879 |
2,317,071 |
41,923 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):